Glostrup / Ann Arbor / Osaka / Taipei / Pittsburgh / Changhua / Indianapolis / St. Louis / Rockville / Helsinki / Baltimore / Cambridge / San Diego / Chicago / Chiayi / Edinburgh / /
Company
SPSS Inc. / Packman LC / Sherman M. Management / Sk-Hep1 PLC / BD Biosciences / IgG / LG / Health Science Research Resources Bank / Bayer Pharmaceuticals / Bruix J / Roche Pharmaceuticals / HP / Creative Commons / Macmillan Publishers Limited / /
Country
Switzerland / Japan / United Kingdom / Scotland / Denmark / Taiwan / United States / / /
Facility
National Taiwan University / Jen Catholic University / DNA complex / Cardinal Tien Hospital / National Laboratory Animal Center / St. Martin De Porres Hospital / Fu Jen Catholic University / Institute of Biopharmaceutical Sciences / National Taiwan University Hospital / National Yang-Ming University / Kaohsiung Medical University / Trail PA / Changhua Christian Hospital / Taipei Veterans’ General Hospital / / /
IndustryTerm
genetic regulatory networks / cancer therapy / /
MedicalCondition
unresectable hepatocellular carcinoma / cervical and endometrial cancers / JE / potential cancer / advanced hepatocellular cancer / hepatitis B / chronic inflammation / endometrial carcinoma / prostate cancer / PLC5 xenograft tumor / breast cancer / lung and oral cancer / human triple negative breast cancer / leukemia / tumor / cervical and endometrial carcinoma / cancer / TD52-induced HCC tumor / tumors / hepatocellular carcinoma / Hino O. Hepatitis C / TD52-induced cancer / HCV / C infection / malignant diseases / mean tumor / human hepatocellular carcinoma / clinical tumor / S-phase arrest cancer / tissue and human colon carcinoma / advanced disease / Wilms’ tumors / advanced hepatocellular carcinoma / vivo tumor / clinical liver tumor / reluctant tumor / Hepatocellular cancer / hepatitis C / J Cancer / Xenograft tumor / important tumor / Piche A. Ovarian cancer / human renal cell carcinoma / PLC5 xenograft tumors / human breast cancer / cancers / necrosis / common cancer / Disease / modest disease / Decreased tumor / TD52-induced tumor / Pisani P. Estimating the world cancer / human colorectal carcinoma / different malignant diseases / lung cancer / Mol Cancer / /
MedicalTreatment
radiotherapy / Surgery / cancer therapy / anticancer therapy / chemotherapy / /
OperatingSystem
Microsoft Windows / /
Organization
Taipei Veterans’ General Hospital / St. Martin De Porres Hospital / Kaohsiung Medical University / Kaohsiung / National Taiwan University / School of Medicine / Department of Medicine / Fu-Jen Catholic University / FDA / Institutional Laboratory Animal Care and Use Committee / National Yang-Ming University / Institute of Biopharmaceutical Sciences / National Laboratory Animal Center / Cardinal Tien Hospital / National Science Council / National Taiwan University Hospital / Use Committee / Changhua Christian Hospital / Department of Medical Research / 2National Center of Excellence for Clinical Trial and Research / 9Medical Research Center / /
Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A